Viimane versioon :
28/04/2024
Mitmesugune   Filgrastim  
Süsteravim
Stabiilsus lahustes Stabiilsust mõjutavad tegurid Stabiilsust mõjutavad faktorid Sobimatus Manustamis viis Viited Pdf

Kaubanduslikud nimed erinevates maades   Kaubanduslikud nimed erinevates maades     

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Accofil Belgia, Saksamaa, Suurbritannia
Biocilin Mehhiko
Duperan Tšiili
Filgen Argentiina
Foltran Tšiili
Granulokine Itaalia, Kreeka
Hebervital Kolumbia
Inmunef Kolumbia
Leucosos Kolumbia
Lioplim Tšiili
Neupogen Ameerika ühendriigid, Austria, Belgia, Hispaania, Holland, Horvaatia, Lõuna Aafrika Vabariik, Poola, Portugal, Prantsusmaa, Rootsi, Sloveenia, Soome, Suurbritannia, Sveits, Taani, Türgi
Neutromax Argentiina
Neutropine Argentiina
Nivestim Belgia, Holland, Norra, Prantsusmaa, Saksamaa, Suurbritannia
Ratiograstim Austria, Rootsi, Saksamaa, Suurbritannia
Tevagrastim Holland, Norra, Rootsi, Saksamaa, Suurbritannia, Sveits
Viited   Süsteravim   Viited : Filgrastim  
Tüüp Avaldamine
99 Ajaleht Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104 Ajaleht Hall PD, Yui D, Lyons S, Bosso JA.
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 185-189.
182 Ajaleht Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 Ajaleht Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269 Ajaleht Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128 Labor Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3249 Ajaleht Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256 Ajaleht Burnett B, Radic I.
Stability of Hospira filgrastim following changes to thermal and photic storage conditions.
EJHP 2011 ; 17, 5: 49-56.
3474 Labor Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3618 Labor Filgrastim (Neupogen®) - Summary of Product Characteristics
Amgen 2014
3828 Plakat Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 Plakat So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055 Ajaleht Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380 Labor Posaconazole (Noxafil®) - Summary of Product Characteristics
Merck Sharp & Dohme Limited 2019
4471 Labor Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4521 Ajaleht Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020
4650 Labor Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.
Advanz Pharma 2021

  Mentions Légales